InvestorsHub Logo

Long-vestor

02/06/15 2:29 PM

#2777 RE: Dragonwing #2750

Because that brief is immaterial currently.. you have to fast forward into the most recent event. which, if you read it, would indicate the litigation has changed from a suite for non performance of payment into litigation of whether Biosuccess has been performing under the terms. For whatever reason, payment according to 'verbal' terms has changed into a litigation as to whether boisccess has been working on the phases of study. Moreover, progressing with the studies and patent application. Those, unfortunately do not appear availed on the net, but, accordingly there was to be a trial held Jan 2015. The results of a trial are not visible too. from what I could gather it was stayed.

However, were I somebody who believed that the $4 million wasn't being dumped right now as we speak, I'd be paying the courts for disclosure of the most recent documents. Especially of fact that Chang fails to mention the litigation at any time in news or interview.

Yet, this whole S-1 and effect notice is very, very telling. This is a notice to 'investors' of a massive dump! And it's not simply warning of a dump, it warns of the right to "Put" (short) cover and then dump.

The purchase price per share to be paid by Macallan shall be calculated as a thirty five percent (35%) discount to the lesser of: (1) the lowest traded price of the Company Common Stock during the ten (10) consecutive trading days prior to the date the Drawdown Notice was submitted or

That's dump price @ 35% discount off of .0008 = 0.00052!!! Those .00052 shares are what Macallan would be using to cover their "put"


(the “Macallan Investment Agreement”). The Macallan Investment Agreement permits us to “put” up to $4,000,000 in shares of our common stock to Macallan over a period of up to thirty-six (36) months.

We are currently authorized to issue 37,503,000,000 shares of our common stock. We may be required to increase our authorized shares in order to receive the entire purchase price. Macallan has agreed to refrain from holding an amount of shares which would result in Macallan owning more than 4.99% of the then-outstanding shares of our common stock at any one time.


And this is when SEC allowed it:
NOTICE OF EFFECTIVENESS

Effective Date:
October 03, 2014

Form:
S-1

Helter Skelter

02/06/15 3:18 PM

#2808 RE: Dragonwing #2750

So... > richard chang (ceo's dad) valued his half of the patent rights, back in 2008, at $1,000,000? They've (the patent rights) now been impaired by rcha @ $0...?

Over $3,000,000 has traded, of this crap, with someone(s) pulling in nearly $2,000,000 (my estimate) for an 8 year old patent that has no apparent value...?

That's why I call the patent a prop.

A prop to sell shares.

Same with the trials, if they can ever be funded.

Patent a prop.
Trials a prop.

There will never be a drug product to sell... >>> only shares...we all should know that.

Thanks for the post, good stuff, great DD...thanks for sharing...